Nostrum Laboratories, Inc. Expands Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Nostrum Laboratories, Inc. is voluntarily recalling one lot of Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) to the consumer level. The Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) have been found to con (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 25, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Metformin Treatment Again Linked to Fewer Deaths From COVID-19 Metformin Treatment Again Linked to Fewer Deaths From COVID-19
The latest of several studies, this time in a very diverse population, shows a striking threefold reduction in deaths from COVID-19 in those taking this leading treatment for type 2 diabetes.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 20, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news
Metformin Treatment Again Linked to Fewer Deaths From COVID-19 Metformin Treatment Again Linked to Fewer Deaths From COVID-19
The latest of several studies, this time in a very diverse population, shows a striking threefold reduction in deaths from COVID-19 in those taking this leading treatment for type 2 diabetes.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - January 20, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
Metformin use reduces risk of death for patients with COVID-19 and diabetes
Use of the diabetes drug metformin - before a diagnosis of COVID-19 - is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19. (Source: World Pharma News)
Source: World Pharma News - January 18, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Metformin use reduces risk of death for patients with COVID-19 and diabetes
(University of Alabama at Birmingham) Use of the diabetes drug metformin -- before a diagnosis of COVID-19 -- is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19. This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 14, 2021 Category: Infectious Diseases Source Type: news
Granules gets American drug regulator's nod for diabetes management drug Metformin
The US Food and Drug Administration (USFDA) has granted final approval for the company's abbreviated new drug application (ANDA) for Metformin Hydrochloride extended-release tablets USP, 500 mg and 1000 mg, Granules said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 13, 2021 Category: Pharmaceuticals Source Type: news
Another Lot of Extended-Release Metformin Is Recalled in the US Another Lot of Extended-Release Metformin Is Recalled in the US
Adding to two lots recalled in November, Nostrum Laboratories has issued a voluntary recall for another lot of extended-release metformin 750 mg due to possible contamination with NDMA.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 7, 2021 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
More Metformin Is Recalled
Another Lot of Extended-Release Metformin Is Recalled in the US (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 7, 2021 Category: General Medicine Source Type: news
Nostrum Laboratories, Inc. Expands Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Nostrum Laboratories, Inc. is voluntarily recalling one lot of Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) to the consumer level. The Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) have been found to con (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 5, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Can early drug intervention prevent weight gain in children with mental illness?
(University of Houston) A University of Houston pharmacological researcher believes that prescribing the drug Metformin for children and teens as soon as they are diagnosed with mental illnesses, like bipolar disorder and schizophrenia, may save them from gaining an enormous amount of weight. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 16, 2020 Category: International Medicine & Public Health Source Type: news
Metformin Use May Reduce Mortality in Women With COVID-19
WEDNESDAY, Dec. 9, 2020 -- For women with type 2 diabetes or obesity who are admitted to the hospital with COVID-19, metformin use is associated with significantly reduced mortality, according to a study published online Dec. 3 in The Lancet Healthy... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 9, 2020 Category: Pharmaceuticals Source Type: news
Pilot Study Looks at Metformin in COVID-19 Pilot Study Looks at Metformin in COVID-19
Small RCT will look at whether metformin has an impact on COVID-19, starting with inflammatory markers and viral load, but hoping to expand to outcomes.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - December 7, 2020 Category: Infectious Diseases Tags: Diabetes & Endocrinology News Source Type: news
New studies show diabetes drug not proven to improve blood sugar control in pediatric patients
The FDA has approved labeling changes stating that Januvia (sitagliptin), Janumet (sitagliptin and metformin hydrochloride), and Janumet XR (sitagliptin and metformin hydrochloride extended-release) are not proven to improve glycemic (blood sugar) control in pediatric patients. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 4, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Study finds metformin reduced COVID-19 death risks in women
University of Minnesota Medical School and UnitedHealth Group (NYSE: UNH) researchers found that metformin was associated with significantly reduced COVID-19 death risks in women in one of the world's largest observational studies of COVID-19 patients.
Metformin is an established, generic medication for managing blood sugar levels in patients with type 2 diabetes. (Source: World Pharma News)
Source: World Pharma News - December 3, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Study finds metformin reduced COVID-19 death risks in women
(University of Minnesota Medical School) University of Minnesota Medical School and UnitedHealth Group researchers found that metformin was associated with significantly reduced COVID-19 death risks in women in one of the world's largest observational studies of COVID-19 patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 3, 2020 Category: International Medicine & Public Health Source Type: news
